Abstract
Aim
The aim of the study was to develop and evaluate an educational intervention for practicing physicians for reporting of adverse drug reactions.
Subjects and Methods
Reporting of adverse drug reactions (ADRs) by healthcare professionals is paramount for improving medicine safety. However, the under-reporting of ADR by physicians is a global problem. A 1-day workshop (comprising a lecture and an information pamphlet) on awareness about ADR reporting and pharmacovigilance system was organized. A pre-tested questionnaire with four questions about ADR reporting and eight on pharmacovigilance system was filled in by the participants before and after the workshop. Descriptive statistics was used for the analysis of demographics as mean and percentage. A paired sample t-test was employed to evaluate the responses before and after the intervention regarding knowledge about ADR reporting and pharmacovigilance system.
Results
There was no significant difference in the pre-post evaluation of knowledge about ADR reporting; however, a significant difference was found in the pre-post evaluation of participant’s knowledge regarding pharmacovigilance system.
Conclusion
The knowledge about the pharmacovigilance system improved after the intervention. Further studies are required on a larger scale and involving other healthcare professionals to promote a better healthcare system.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- ADR:
-
Adverse drug reaction
- DRAP:
-
Drug Regulatory Authority of Pakistan
- KADR:
-
Knowledge about adverse drug reaction
- KPV:
-
Knowledge about phaarmacovigilance
- WHO:
-
World Health Organization
References
Bisht M, Singh S, Dhasmana D (2014) Effect of educational intervention on adverse drug reporting by physicians: a cross-sectional study. ISRN Pharmacol 2014:259476. https://doi.org/10.1155/2014/259476
Goldman SA (2004) Communication of medical product risk. Drug Saf 27(8):519–534. https://doi.org/10.2165/00002018-200427080-00005
Goold SD, Lipkin M (1999) The doctor–patient relationship: challenges, opportunities, and strategies. J Gen Intern Med 14(Suppl 1):S26. https://doi.org/10.1046/j.1525-1497.1999.00267.x
Hazell L, Shakir S (2006) Underreporting of adverse drug reactions: a systematic review. Drug Saf 29:385–396. https://doi.org/10.2165/00002018-200629050-00003
Hussain R, Hassali MA, Hashmi F, Farooqui M (2018) A qualitative exploration of knowledge, attitudes and practices of hospital pharmacists towards adverse drug reaction reporting system in Lahore, Pakistan. J Pharm Policy Pract 11(1):16. https://doi.org/10.1186/s40545-018-0143-0
Inman W (1996) Attitudes to adverse drug reaction reporting. Br J Clin Pharmacol 41(5):434–435
Jha N, Rathore DS, Shankar PR, Gyawali S, Alshakka M, Bhandary S (2014) An educational intervention’s effect on healthcare professionals’ attitudes towards pharmacovigilance. Australas Med J 7(12):478. https://doi.org/10.4066/AMJ.2014.2235
Nisa ZU, Zafar A, Sher F (2018) Assessment of knowledge, attitude and practice of adverse drug reaction reporting among healthcare professionals in secondary and tertiary hospitals in the capital of Pakistan. Saudi Pharm J 26(4):453–461. https://doi.org/10.1016/j.jsps.2018.02.014
Passier A, ten Napel M, van Grootheest K, van Puijenbroek E (2009) Reporting of adverse drug reactions by general practitioners. Drug Saf 32(10):851–858. https://doi.org/10.2165/11314490-000000000-00000
Varallo FR, Planeta CS, Mastroianni PC (2017) Effectiveness of pharmacovigilance: multifaceted educational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff. Clinics (Sao Paulo) 72(1):51–57. https://doi.org/10.6061/clinics/2017(01)09
World Health Organization (2017) Medication without harm—global patient safety challenge on medication safety. https://www.who.int/patientsafety/medication-safety/en/. Accessed 13 March 2019
Acknowledgements
We are very grateful to the Dean, Institute of Postgraduate Studies, Universiti Sains Malaysia, the Dean of the University Institute of Public Health, University of Lahore, and workshop participants for their generous support in conducting this project.
Funding
This work was supported by The Institute of Post Graduate Studies, Universiti Sains Malaysia, under Post-Graduate Research Attachment (PGRA) funding.
Author information
Authors and Affiliations
Contributions
Conceptualized the study: RH and AH. Collected the data, performed the analysis and drafted the first manuscript: RH and SR. Critically reviewed, revised the manuscript: AH and SR. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Written informed consent was obtained from all participants included in the study.
Ethics approval
The study was approved by the Humans Ethics Committee (HEC), University College of Pharmacy, University of the Punjab, Lahore, Pakistan, with reference no. HEC/PUCP/1943.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Supplementary File 1
(DOCX 24 kb)
Supplementary File 2
(DOCX 176 kb)
Supplementary File 3
(DOCX 14 kb)
Supplementary File 4
(DOCX 13 kb)
Rights and permissions
About this article
Cite this article
Hussain, R., Hassali, M.A. & Rana, S.M. Evaluation of an educational intervention on physicians’ knowledge about adverse drug reaction reporting system. J Public Health (Berl.) 29, 159–162 (2021). https://doi.org/10.1007/s10389-019-01116-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10389-019-01116-x